Related Experiment Video
Updated: Sep 13, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
MMP-9 Activation via ROS/NF-κB Signaling in Colorectal Cancer Progression: Molecular Insights and
Andrej Veljkovic1, Goran Stanojevic2, Branko Brankovic2
1Faculty of Medicine, University of Nis, 18000 Nis, Serbia.
Colorectal cancer progression involves oxidative stress and inflammation, linked by the ROS-NF-κB-MMP-9 pathway. MMP-9 shows high predictive value for CRC, suggesting it as a key diagnostic marker.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Colorectal cancer (CRC) involves complex interactions between inflammation, oxidative stress, and extracellular matrix remodeling.
- The reactive oxygen species (ROS)-nuclear factor kappa B (NF-κB)-matrix metalloproteinase-9 (MMP-9) axis is significant in CRC invasion and metastasis.
- Understanding this axis is crucial for developing targeted therapies.
Purpose of the Study:
- To analyze advanced oxidation protein products (AOPPs), NF-κB expression, and MMP-9 activity in CRC tissues.
- To investigate the correlation between oxidative stress markers and MMP-9 activity.
- To evaluate MMP-9 as a potential diagnostic and theranostic marker for CRC.
Main Methods:
- Analysis of AOPPs, NF-κB, and MMP-9 in tumor, adjacent, and healthy colon tissues from 50 CRC patients.
- Utilized ELISA, spectrophotometry, and indirect immunofluorescence for biochemical analyses.
- Correlated marker levels with clinical data and disease progression.
Main Results:
- Significantly elevated AOPPs, NF-κB, and MMP-9 in tumor tissues compared to controls.
- Adjacent tissues showed increased NF-κB and MMP-9 compared to healthy tissues.
- AOPP levels strongly correlated with MMP-9 activity; MMP-9 had the highest predictive value for CRC.
Conclusions:
- The ROS-NF-κB-MMP-9 axis is integral to colorectal cancer progression, particularly in T2-T3 stages.
- MMP-9 emerges as a promising diagnostic and theranostic marker for CRC.
- Targeting this pathway offers potential therapeutic strategies for CRC invasion and recurrence.
More Related Videos
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
PI3K/mTOR/AKT Signaling Pathway